Malo J L, Ghezzo H, L'Archevêque J, Cartier A
Department of Chest Medicine, Hôpital du Sacré-Coeur, Montreal, Quebec, Canada.
J Allergy Clin Immunol. 1990 May;85(5):834-42. doi: 10.1016/0091-6749(90)90065-c.
Late asthmatic reactions have been demonstrated, generally, to increase bronchial responsiveness and are believed to respond poorly to inhaled bronchodilator. To assess the frequency of changes in bronchial responsiveness, we reviewed the records of 101 subjects with late asthmatic reactions and of 63 subjects with isolated immediate reactions after specific inhalation challenges to various occupational agents. These subjects had undergone nonspecific inhalation challenges to histamine or methacholine on a control day and after the late reaction when FEV1 had returned to +/- 10% baseline. We also reviewed 99 cases of subjects with late reactions who were administered an inhaled beta 2-agent (albuterol, 200 micrograms) during the late reaction. Fifty-seven/101 (56%) subjects with late reactions and 24/63 (38%) subjects with isolated immediate reactions demonstrated a twofold or greater change in provocative concentration of histamine or methacholine causing a 20% change in FEV1 (PC20) from baseline (p = 0.02; odds for the presence of significant changes in PC20 in subjects with late reactions, 56%; odds for the absence of significant changes in PC20 in subjects with immediate reactions, 62%). Changes in FEV1 greater than 20% after administering albuterol at the time of the late reactions occurred in 78% of the subjects tested; in 66%, FEV1 returned to greater than 90% baseline. This retrospective study demonstrates that changes in bronchial responsiveness after late reactions are not constant and do not appear to distinguish satisfactorily late from immediate reactions. Furthermore, late reactions respond well to beta 2-agonist.(ABSTRACT TRUNCATED AT 250 WORDS)
一般来说,迟发性哮喘反应已被证实会增加支气管反应性,并且被认为对吸入性支气管扩张剂反应不佳。为了评估支气管反应性变化的频率,我们回顾了101例有迟发性哮喘反应的受试者以及63例在对各种职业性过敏原进行特异性吸入激发试验后仅有速发反应的受试者的记录。这些受试者在对照日以及迟发性反应后、第一秒用力呼气容积(FEV1)恢复到基线水平±10%时,接受了组胺或乙酰甲胆碱的非特异性吸入激发试验。我们还回顾了99例在迟发性反应期间接受吸入β2受体激动剂(沙丁胺醇,200微克)治疗的迟发性反应受试者的病例。101例迟发性反应受试者中有57例(56%)、63例仅有速发反应的受试者中有24例(38%),其组胺或乙酰甲胆碱激发浓度导致FEV1从基线水平变化20%(PC20)出现了两倍或更大的变化(p = 0.02;迟发性反应受试者中PC20出现显著变化的几率为56%;速发反应受试者中PC20无显著变化的几率为62%)。在迟发性反应时给予沙丁胺醇后,78%的受试受试者FEV1变化大于20%;66%的受试者FEV1恢复到基线水平的90%以上。这项回顾性研究表明,迟发性反应后支气管反应性的变化并不恒定,似乎也不能令人满意地区分迟发性反应和速发反应。此外,迟发性反应对β2受体激动剂反应良好。(摘要截选至250字)